Search Results 681-690 of 16988 for pharmacogenetics
Mayo Clinic doctors are leaders in conducting clinical trials of Hodgkin lymphoma treatments that are more effective and less toxic.
What is the incidence and etiology of bone overgrowth in protein versus other bone graft? Participation eligibility. Participant eligibility includes age, ...
Rochester, Minn. The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected ...
A leukapheresis procedure will be performed to manufacture bb2121 chimeric antigen receptor (CAR) modified T cells. Prior to bb2121 infusion subjects will ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
An international team, including researchers from MayoClinic, has discovered a gene so powerful it nearly triples the risk of Alzheimer's disease.
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
Diagnosis · Biopsy · Blood tests · Imaging tests · Testing lymphoma cells in the lab · Care at Mayo Clinic · More Information.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!